Growth Of In Vivo Toxicology Market

1. In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022 The In Vivo Toxicology Market is expected to reach USD 6.14 Billion by 2022 from an estimated USD 4.40 Billion in 2017, at a CAGR of 6.9%. According to the new market research report "In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub- chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In- house) - Global Forecast to 2022", published by MarketsandMarkets™. Don’t miss out on business opportunities in In Vivo Toxicology Market. The key factors driving the growth of this market include increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests. The consumables segment is expected to hold the largest share of the market Based on product, the In Vivo Toxicology Market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. In 2017, the consumables segment is expected to account for the largest share of the In Vivo Toxicology Market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis. Browse and in-depth TOC on "In Vivo Toxicology Market" 124 - Tables 38 - Figures 196 - Pages View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/in-vivo-toxicology-testing-market- 105308811.html By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period The In Vivo Toxicology Market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.

2. Request for Free Sample Report @ https://www.marketsandmarkets.com/pdfdownload.asp?id=105308811 The US is expected to dominate the In Vivo Toxicology Market in 2017 In 2017, the US is estimated to account for the largest share of the In Vivo Toxicology Market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the In Vivo Toxicology Market in China. The major players in the global In Vivo Toxicology Market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US). Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact Us: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062

3. USA: +1-888-600-6441 Email: sales@marketsandmarkets.com